---
title: "Top 5 CDRs Gainers/Losers (>100M) (4.8)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282102083.md"
description: "ECARX(ECX) rose 14%, with a trading turnover 1.5 Million USD, and a year-to-date fell 33.7%. Futu(FUTU) rose 11.47%, with a trading turnover 543.3 Million USD, and a year-to-date fell 4.3%. Adagene(ADAG) fell 9.71%, with a trading turnover 3.9 Million USD, and a year-to-date rose 111.6%. Connect Biopharma(CNTB) fell 6.74%, with a trading turnover 1.3 Million USD, and a year-to-date fell 6.7%."
datetime: "2026-04-08T22:00:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282102083.md)
  - [en](https://longbridge.com/en/news/282102083.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282102083.md)
---

# Top 5 CDRs Gainers/Losers (>100M) (4.8)

NASDAQ Composite Index has rose 2.8%, with a year-to-date fell 2.6%; S&P 500 has rose 2.51%, with a year-to-date fell 0.9%; Dow Jones Industrial Average has rose 2.85%, with a year-to-date fell 0.3%.

ECARX(ECX) rose 14%, with a trading turnover 1.5 Million USD, and a year-to-date fell 33.7%.

Futu(FUTU) rose 11.47%, with a trading turnover 543.3 Million USD, and a year-to-date fell 4.3%.

Adagene(ADAG) fell 9.71%, with a trading turnover 3.9 Million USD, and a year-to-date rose 111.6%.

Connect Biopharma(CNTB) fell 6.74%, with a trading turnover 1.3 Million USD, and a year-to-date fell 6.7%.

### Related Stocks

- [ECX.US](https://longbridge.com/en/quote/ECX.US.md)
- [FUTU.US](https://longbridge.com/en/quote/FUTU.US.md)
- [GCT.US](https://longbridge.com/en/quote/GCT.US.md)
- [ACMR.US](https://longbridge.com/en/quote/ACMR.US.md)
- [HSAI.US](https://longbridge.com/en/quote/HSAI.US.md)
- [ADAG.US](https://longbridge.com/en/quote/ADAG.US.md)
- [CNTB.US](https://longbridge.com/en/quote/CNTB.US.md)
- [ZEPP.US](https://longbridge.com/en/quote/ZEPP.US.md)
- [CHSN.US](https://longbridge.com/en/quote/CHSN.US.md)
- [UXIN.US](https://longbridge.com/en/quote/UXIN.US.md)

## Related News & Research

- [Short Interest in ACM Research, Inc. (NASDAQ:ACMR) Decreases By 14.5%](https://longbridge.com/en/news/284929651.md)
- [ECARX Announces Acquisition Plan | ECX Stock News](https://longbridge.com/en/news/282007352.md)
- [ACM Research Announces Preliminary Unaudited Revenue and Shipments for the First Quarter 2026 | ACMR Stock News](https://longbridge.com/en/news/284214185.md)
- [Connect Biopharma Advances Enrolment In Phase 2 Seabreeze STAT Trial For Asthma Drug Rademikibart](https://longbridge.com/en/news/283976564.md)
- [ECARX Announces Audited 2025 Full-Year Financial Results | ECX Stock News](https://longbridge.com/en/news/281530667.md)